2019-04-19 |
103 |
Answer to Amended Complaint |
that U.S. Patent Numbers
7,449,012, 7,794,432, 8,048,035 and 8,870,827 each have a patent expiration…Technologies Inc. is the
assignee to U.S. Patents Nos. 7,449,012, 7,794,432, 8,048,035, 8,870,827 and 9,…Technologies, Inc. is the assignee for U.S. Patent Numbers
7,449,012, 7,794,432, 8,048,035 and 8,870,827, and…095,664, filed Apr. 1, 2005,
now U.S. Pat. No. 7,449,012, which claims the benefit of U.S. Provisional …information, U.S. Patent Number
4,031,893 was filed on May 14, 1976, that U.S. Patent Number 4,031,893 |
External link to document |
2019-06-17 |
114 |
Amended Complaint |
expiration of U.S. Patent Nos.
7,449,012 B2 (the “‘012 patent”) and 7,794,432 B2 (the “‘432 patent”), which expire…Numbers 7,449,012, 7,794,432, 8,048,035, and 8,870,827 (the “EpiPen Patents”). These four
patents have a …additional patents for features that were subsequently integrated into the EpiPen: U.S. Patent
Numbers…The issuance of the EpiPen Patents, and Mylan’s designation of these patents as
covering the EpiPen, …submitted information concerning the ’012 patent and ’432 patent for listing in the FDA’s
[Orange Book |
External link to document |
2019-07-31 |
123 |
Third Amended Complaint |
expiration of U.S. Patent Nos.
7,449,012 B2 (the “‘012 patent”) and 7,794,432 B2 (the “‘432 patent”), which expire…Numbers 7,449,012, 7,794,432, 8,048,035, and 8,870,827 (the “EpiPen Patents”). These four
patents have a …additional patents for features that were subsequently integrated into the EpiPen: U.S. Patent
Numbers…The issuance of the EpiPen Patents, and Mylan’s designation of these patents as
covering the EpiPen, …submitted information concerning the ’012 patent and ’432 patent for listing in the FDA’s
[Orange Book |
External link to document |
2020-04-27 |
144 |
Answer to Amended Complaint |
that U.S. Patent Numbers
7,449,012; 7,794,432; 8,048,035 and 8,870,827 each have a patent expiration…Technologies Inc. is the
assignee to U.S. Patent Nos. 7,449,012; 7,794,432; 8,048,035; 8,870,827; and 9,…Technologies, Inc. is the assignee for U.S. Patent Numbers
7,449,012; 7,794,432; 8,048,035 and 8,870,827, and…095,664, filed Apr. 1, 2005,
now U.S. Pat. No. 7,449,012, which claims the benefit of U.S. Provisional …information, U.S. Patent Number 4,031,893 was
filed on May 14, 1976, that U.S. Patent Number 4,031,893 |
External link to document |
2017-03-20 |
39 |
Amended Complaint |
expiration of U.S. Patent Nos.
7,449,012 B2 (the “‘012 patent”) and 7,794,432 B2 (the “‘432 patent”), which expire…7,449,012, 7,794,432, 8,048,035, and 8,870,827 (the “EpiPen Patents”). These four
patents have a priority…settling
its patent infringement suit against Teva Pharmaceuticals (“Teva”) relating to the patents
covering…additional patents for features that were subsequently integrated into the EpiPen: U.S. Patent
Numbers…The issuance of the EpiPen Patents, and Mylan’s designation of these patents as
covering the EpiPen, |
External link to document |
2017-05-30 |
45 |
Consolidated Amended Complaint |
expiration of U.S. Patent Nos.
7,449,012 B2 (the “‘012 patent”) and 7,794,432 B2 (the “‘432 patent”), which expire…7,449,012, 7,794,432, 8,048,035, and 8,870,827 (the “EpiPen Patents”). These four
patents have a priority…settling
its patent infringement suit against Teva Pharmaceuticals (“Teva”) relating to the patents
covering…additional patents for features that were subsequently integrated into the EpiPen: U.S. Patent
Numbers…The issuance of the EpiPen Patents, and Mylan’s designation of these patents as
covering the EpiPen, |
External link to document |
2018-04-25 |
75 |
Answer to Amended Complaint |
that U.S. Patent Numbers 7,449,012,
7,794,432, 8,048,035 and 8,870,827 each have a patent expiration…Technologies Inc. is the assignee to U.S.
Patents Nos. 7,449,012, 7,794,432, 8,048,035, 8,870,827 and 9,…Technologies, Inc. is the assignee for U.S. Patent Numbers 7,449,012,
7,794,432, 8,048,035 and 8,870,827, …095,664, filed Apr. 1, 2005, now U.S. Pat.
No. 7,449,012, which claims the benefit of U.S. Provisional …information, U.S. Patent Number 4,031,893 was filed on
May 14, 1976, that U.S. Patent Number 4,031,893 |
External link to document |